Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
8 Cards in this Set
- Front
- Back
|
A patient who has Parkinson's disease takes levodopa and Carbidopa. The patient asks the NP why 2 drugs are necessary. The NP should explain death both drugs are needed to |
Decrease adverse peripheral side effects. Combining Carbidopa with levodopa results in increased concentrations of levodopa in the central nervous system and decreased conversion of levodopa to dopamine in the periphery, where it causes adverse effects. Carbidopa does not prolong the effects of levodopa. The combination does not cause delay and disease progression and does not enhance passage across the blood-brain barrier |
|
|
A patient who has Parkinson's disease and who takes levodopa reports that the drug effects wear off more quickly than before. The NP should |
Add a monoamine oxidase B inhibitor Mao - B. When an MAO B is given it appears to enhance and prolong the response of levodopa, reducing the wearing off effect. Carbidopa does not alter this effect. Amantadine it's not indicated. Increasing the dose of levodopa is not indicated |
|
|
A patient who has Parkinson's disease takes levodopa and Carbidopa. The patient reports experiencing Tremors between doses. The NP should |
Add entacapone. Catecholamine o - methyltransferase Inhibitors, such as entacapone, are used to prolong the effects of levodopa and help prevent breakthrough Tremors that occur before the next dose of levodopa. Amantadine is not indicated. Increasing Carbidopa does not have this effect. Increasing the dose of levodopa does not prolong its effects |
|
|
A patient who takes levodopa and Carbidopa for Parkinson's Disease reports experiencing freezing episodes between doses. The NP should consider using |
Apomorphine. Apomorphine injection is used for acute treatment of immobility known as freezing |
|
|
A patient who has Parkinson's disease who takes levodopa and Carbidopa reports having drooling episodes that are increasing in frequency. The NP should order |
Benztropine. Anticholinergics are used to control drooling |
|
|
A patient who is diagnosed with Parkinson's disease will begin taking levodopa and Carbidopa. The patient asks the NP what dietary interventions may be helpful in improving symptoms. The NP should recommend |
Minimizing intake of high protein foods during the day. Some people find that avoiding high protein foods during the day and hoarding them until the evening improves Mobility during the day. Because of decreased activity associated with the disease, patients should not eat a diet high in calories. A low-carb diet is not indicated. Patients should consume plenty of water with food to Aid in chewing and swallowing |
|
|
A 55 year old patient develops Parkinson's disease characterized by unilateral Tremors only. The NP will refer the patient to a neurologist and should expect initial treatment to be |
Pramipexole. Patients younger than 65 years of age should be started with a dopamine Agonist |
|
|
A 65 year old patient is diagnosed with Parkinson's disease. The patient has emphysema and narrow angle glaucoma. The NP should consider beginning therapy with |
Selegiline. Selegiline is safe for patients with glaucoma and emphysema. Benztropine is contraindicated in patients with glaucoma and emphysema. Dopamine precursors, such as Carbidopa levodopa, are contraindicated in patients with narrow angle glaucoma and cautioned in patients with emphysema |
